Font Size: a A A
Keyword [Programmed cell death-Ligand 1]
Result: 21 - 38 | Page: 2 of 2
21. Clinicopathological Study On The Expression Of PD-L1(Ventana SP142)in Breast Cancer Infiltrating Immune Cells
22. The Expression Of PD-1/PD-L1 In HNSCC Tissues And The Expression And Dynamic Changes Of SPD-L1 In Peripheral Blood
23. Clinical Significance Of Expression Of Programmed Cell Death Receptor 1 And Its Ligands In Patients With Endometrial Cancer
24. NAD~+ Metabolism Maintains Inducible PD-L1 Expression To Drive Tumor Immune Evasion
25. Clinical Exploration Into Immunotherapy Based On The PD-L1 Expression In Non-Small Cell Lung Cancer
26. Construction Of Sentinel Lymph Node Metastasis Prediction Model(PUMCH-SLN) For Breast Cancer And The Mechanism Of P53/AKT/JAK-STAT Regulatory Network Regulating Immune Escape Of Breast Cancer Cells
27. Research On The Prognostic Significance Of Systemic Immune-inflammation Index And Tumor Infiltrating Lymphocytes In Nasopharyngeal Carcinoma
28. Y Chromosome Traces The Micro-chimerism Of Exogenous Tolerant DCs In CIA Rats
29. Correlation Between 18F-FDG PET/CT Metabolic Parameters And PD-L1 Expression And Clinicopathological Characteristics In Non-Small Cell Lung Cancer
30. Expression Of Immune Checkpoint Molecules TIM-3,PD-1 And Its Ligand PD-L1 In DLBCL And Their Bioinformatics Analysis In Tumor Immunity
31. The Diagnosis Value Of Exosomal PD-L1 In Non-small Cell Lung Cancer Based On Electroosmotic Pump Microfluidic Chip
32. Tumor Immune Microenvironment Subtyping And Its Multi-omics Molecular Features In The Evaluation Of The Efficacy And Prognosis Of Anti-PD-1/PD-L1 Immunotherapy
33. Clinical Value Of PD-L1 Expression And Peripheral Blood Routine After Immunotherapy In Patients With Wild-type Advanced Non-small Cell Lung Cancer
34. The Expression And Significance Of PD-L1,CD4+T,CD8+T Cell In Colorectal Cancer
35. An Experiment On Role Mechanism Of MiRNA-423-3p Targeting For ISG15 To Regulate PD-L1 In Pancreatic Cancer
36. The Mechanism Of All-trans Retinoic Acid Up-regulating Programmed Cell Death Ligand 1 And Its Anti-tumor Effect In Combination With PD-L1 Antibody In Gastric Cancer
37. The Expression Of Tumor Mutation Board And Programmed Cell Death Ligand 1 In Esophageal Squamous Cell Carcinoma And Its Clinical Significance
38. Preliminary Exploration Of The Death Mechanism Of Head And Neck Squamous Cell Carcinoma Cells Induced By Photothermal Effect Of Gold Nanorods Modified By PD-L1 Monoclonal Antibody
  <<First  <Prev  Next>  Last>>  Jump to